(Q61908019)
Statements
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease (English)
Cosimo Prantera
Herbert Lochs
Maria Grimaldi
Maria Lia Scribano
Retic Study Group (Rifaximin-Eir Treatment in Crohn's Disease)